₁₁Séverine Vermeire

Summary for 2004 [at-glance overview of Séverine Vermeire work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Séverine Vermeire. According to available data, in 2004 Séverine Vermeire published at least 11 articles. This work was completed in collaboration with several authors including Rutgeerts, Paul and Bossuyt, Xavier. Many other authors have collaborated with Séverine Vermeire as well. There is no information about the funding or the grants awarded to support this work.

Séverine Vermeire has rank 12 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that Séverine Vermeire professional interests are focused around "inflammatory bowel disease", "severe ulcerative colitis" and "patients severe ulcerative". These might also be referred to as "inflammatory bowel", "bowel disease" or "nod2 card15". Statistical analysis shows that Séverine Vermeire's writing is likely to contains terms "patients", "disease", "treatment", "card15", "csa" and "cd".

The affiliations of Séverine Vermeire vary, with Department of Medicine, Division of Gastroenterology, University of Hospital Gasthuisberg, Leuven, Belgium being the most prominent. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Séverine Vermeire]

Do you know Séverine Vermeire who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Séverine Vermeire]

₇₁Vermeire, S

Year 2004 Charts [Séverine Vermeire frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Séverine Vermeire publication and funding history for the range of years]

Emails (2) [email addresses extracted from Séverine Vermeire affiliations]

hidden to prevent spam, click here to reveal

Séverine Vermeire Coauthors (19) [all coauthors with the number of joint publications]

9

3

3

3

3

3

2

2

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (7) [condensed summary of the Séverine Vermeire affiliations, the leading number and the color conveys importance]

₃Department of Medicine, Division of Gastroenterology, University of Hospital Gasthuisberg, Leuven, Belgium.
₂Department of Gastroenterology, U.Z. UZ Gasthuisberg, Leuven, Belgium.
₁Laboratory Medicine, Immunology, Internal Medicine, Gastroenterology, Department of Paediatrics, Department of Pathology, University Hospital, Leuven, Belgium.
₁Department of Gastroenterology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.
₁Department of Gastroenterology, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium.
₁Gastroenterology Unit, University hospital Gasthuisberg Leuven, Herestraat 49, 3000 Leuven, Belgium.
₁Department of Internal Medicine, University Hospital, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.

Key Opinion Leader In [Séverine Vermeire is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁₂Colitis, Ulcerative | ₁₇Crohn Disease | ₂₅Inflammatory Bowel Diseases | ₂₄₀Tumor Necrosis Factor-alpha

Keywords (32) [keywords assigned to Séverine Vermeire articles by PubMed, the leading number and the color conveys importance]

₁₁Humans | ₅Crohn Disease | ₅Colitis, Ulcerative | ₅Adult | ₅Middle Aged | ₅Female | ₅Male | ₄Aged | ₃Adolescent | ₃Tumor Necrosis Factor-alpha | ₃Inflammatory Bowel Diseases | ₃Treatment Outcome | ₂Sensitivity and Specificity | ₂Immunosuppressive Agents | ₂Nod2 Signaling Adaptor Protein | ₂Colectomy | ₂Carrier Proteins | ₂Cohort Studies | ₂Biological Markers | ₂Belgium | ₂Antibodies, Antineutrophil Cytoplasmic | ₂Genetic Predisposition to Disease | ₂Prevalence | ₂Fluorescent Antibody Technique, Indirect | ₂Antibodies, Monoclonal | ₂Intracellular Signaling Peptides and Proteins | ₂Aged, 80 and over | ₁Gene Expression | ₁Infant, Newborn | ₁Cytokines | ₁Islets of Langerhans | ₁C-Reactive Protein

Séverine Vermeire Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Séverine Vermeire might be a good expert witness on these terms]

₃₃patients | ₂₂disease | ₁₄treatment | ₁₃card15 | ₁₀csa | ₁₀cd | ₁₀bowel | ₉nod2 | ₉inflammatory | ₈associated | ₈uc | ₇colitis | ₇assays | ₇transmission | ₆diagnostic | ₆iga | ₆ulcerative | ₆anti-tnf | ₅treated | ₅increased | ₅results | ₅strategies | ₄human | ₄antibody | ₄ibd | ₄compared | ₄follow-up | ₄response | ₄ttg | ₄conclusions | ₃predicts | ₃higher
₉inflammatory bowel | ₈bowel disease | ₇nod2 card15 | ₇cd patients | ₆ulcerative colitis | ₄crohn disease | ₃transmission card15 | ₃celiac disease | ₃patients treated | ₃clinical practice | ₃diagnostic accuracy | ₃anti-tnf strategies | ₂relevance clinical | ₂opportunistic infections | ₂second-generation human | ₂numerical values | ₂autoantibodies inflammatory | ₂patients uc | ₂patients ulcerative | ₂human ttg | ₂transglutaminase antibody | ₂ttg antigen | ₂ten second-generation | ₂accuracy ten | ₂assays celiac | ₂disease pancreatic | ₂card15 relevance | ₂antibody assays | ₂protein marker | ₂response drugs | ₂colitis uc | ₂sensitivity specificity
₈inflammatory bowel disease | ₃severe ulcerative colitis | ₃patients severe ulcerative | ₂assays celiac disease | ₂nod2 card15 genotyping | ₂c-reactive protein marker | ₂transglutaminase antibody assays | ₂diagnostic accuracy ten | ₂human ttg antigen | ₂accuracy ten second-generation | ₂protein marker inflammatory | ₂tissue transglutaminase antibody | ₂patients ulcerative colitis | ₂card15 relevance clinical | ₂second-generation human tissue | ₂autoantibodies inflammatory bowel | ₂disease pancreatic autoantibodies | ₂antibody assays celiac | ₂nod2 card15 relevance | ₂human tissue transglutaminase | ₂pancreatic autoantibodies inflammatory | ₂relevance clinical practice | ₂ulcerative colitis uc | ₂ten second-generation human | ₂marker inflammatory bowel | ₂treatment inflammatory bowel | ₂long-term outcome treatment | ₂optimizing anti-tnf treatment | ₂nod2 card15 mutations | ₂nod2 variants within | ₂outcome treatment intravenous | ₂card15 nod2 variants

Reader's Comments (0) [comments posted by readers of Séverine Vermeire profile]